lipanthyl supra 160 mg
viatris healthcare limited, Írsko - fenofibrát - 31 - hypolipidaemica
lipanthyl supra 215 mg
viatris healthcare limited, Írsko - fenofibrát - 31 - hypolipidaemica
lipanthyl nt 145 mg
viatris healthcare limited, Írsko - fenofibrát - 31 - hypolipidaemica
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate mylan
mylan ireland limited - dimetylfumarát - roztrúsená skleróza, recidivujúce-odosielajúcej - imunosupresíva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimetylfumarát - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresíva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate glenmark 240 mg
glenmark pharmaceuticals s.r.o., Česká republika - dimetyl-fumarát - 59 - immunopraeparata
dimethyl fumarate glenmark 120 mg
glenmark pharmaceuticals s.r.o., Česká republika - dimetyl-fumarát - 59 - immunopraeparata